OPTFSNA
CTMX icon

Old Point Trust & Financial Services N A’s CytomX Therapeutics CTMX Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250
Closed -$545 – 402
2024
Q1 		$545 Buy
+250
New +$461 ﹤0.01% 488

Other funds holding CTMX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Old Point Trust & Financial Services N A's CTMX Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of CytomX Therapeutics (CTMX) in Q2 2024, closing a stake of 250 shares — an estimated $545 sold.

Old Point Trust & Financial Services N A first reported a position in CTMX in Q1 2024 and held it in 1 quarter. The position peaked at $545 in Q1 2024. 74 funds tracked by Wall St. Rank hold CTMX as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining CytomX Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 250 CytomX Therapeutics shares in Q2 2024, an estimated $545.
  • Old Point Trust & Financial Services N A first reported a position in CytomX Therapeutics in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's CytomX Therapeutics position peaked at $545 in Q1 2024.
  • 74 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.